From May 12, 2022 to June 30, 2022, the company has repurchased 797,000 shares, representing 0.14% for HKD 2.9 million. With this, the company has completed the repurchase of 797,000 shares, representing 0.14% for HKD 2.9 million under the buyback announced on May 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.59 HKD | +0.39% | +1.97% | +4.02% |
May. 28 | Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2023 | CI |
Mar. 19 | Essex Bio-Technology's 2023 Profit Jumps 22% on Higher Turnover | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.02% | 187M | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+62.61% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.84% | 9.11B |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.